Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14
Frequently Asked Questions
What is Market Cap of Reviva Pharmaceuticals Holdings Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Reviva Pharmaceuticals Holdings Inc. market cap is $28.35M.
What is the 52-week high for Reviva Pharmaceuticals Holdings Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Reviva Pharmaceuticals Holdings Inc. 52 week high is $4.28 as of September 25, 2025.
What is the 52-week low for Reviva Pharmaceuticals Holdings Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Reviva Pharmaceuticals Holdings Inc. 52 week low is $0.2522 as of September 25, 2025.
What is Reviva Pharmaceuticals Holdings Inc. stock price today?
Reviva Pharmaceuticals Holdings Inc. stock price today is $0.295.
What was Reviva Pharmaceuticals Holdings Inc. stock price yesterday?
Reviva Pharmaceuticals Holdings Inc. stock price yesterday was $0.2943.
What is the PE ratio of Reviva Pharmaceuticals Holdings Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Reviva Pharmaceuticals Holdings Inc.’s P/E ratio is -0.45.
What is the Price-to-Book ratio of Reviva Pharmaceuticals Holdings Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Reviva Pharmaceuticals Holdings Inc. P/B ratio is -43.6.
What is the 50-day moving average of Reviva Pharmaceuticals Holdings Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Reviva Pharmaceuticals Holdings Inc. 50-day moving average is $0.4416.
How many employess does Reviva Pharmaceuticals Holdings Inc. has?
Reviva Pharmaceuticals Holdings Inc. has 14 employees.